XFOR - X4 Pharmaceuticals GAAP EPS of -$0.69 beats by $0.10, revenue of $1.76M misses by $0.14M
2025-11-05 12:31:54 ET
More on X4 Pharmaceuticals
- X4 Pharmaceuticals drops 5%, prices $135M equity
- X4 Pharmaceuticals announces proposed underwritten public offering
- Seeking Alpha’s Quant Rating on X4 Pharmaceuticals
- Historical earnings data for X4 Pharmaceuticals
- Financial information for X4 Pharmaceuticals